Global Tuberculosis Diagnostics Market is segmented based on Disease Type, Test Type, End Users, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Tuberculosis Diagnostics Market is segmented based on Disease Type, Test Type, End Users, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Introduction

The Global Tuberculosis Diagnostics Market is estimated to be USD 2.76 Bn in 2023 and is expected to reach USD 3.71 Bn by 2028, growing at a CAGR of 6.12%.

Mycobacterium tuberculosis is a bacterium that causes the potentially dangerous infectious disease known as tuberculosis (TB). Although the lungs are the main organs affected, the kidneys, spine, and brain can also be impacted. When an infected person talks, coughs, or sneezes and releases droplets containing bacteria into the air, TB can be transmitted from one person to another through the air.

According to the World Health Organization’s 2022 Global TB Report, an estimated 10.6 million people fell ill with tuberculosis (TB) in 2021, an increase of 4.5% from 2020, and 1.6 million people died from TB (including 187 000 among HIV-positive people).

A significant global health issue, tuberculosis continues to have a high disease burden, especially in developing nations. A key factor driving the diagnostics market is the requirement for an accurate and timely diagnosis to manage and treat TB patients effectively.

The Tuberculosis Diagnostics Market is being pushed by increased R&D investments, resulting in the development of sophisticated diagnostic devices. These expenditures are intended to improve tuberculosis diagnosis accuracy, speed, and efficiency, consequently driving market growth.

To combat TB globally, governments and international organizations have put in place a number of programs and initiatives. These programs concentrate on expanding access to diagnostics, bolstering the healthcare system, and funding TB control. Government funding and support greatly influence the creation and use of TB diagnostic tools. Rising awareness of tuberculosis and its early detection also contributes to the diagnostics market's growth in these regions.

Point-of-care TB diagnostic tests that can be completed at patients’ locations are in high demand, especially in primary healthcare settings and resource-constrained regions. POC tests provide quick results, enable treatment to start immediately, and reduce reliance on lab infrastructure. Access to TB diagnosis can be increased, especially in areas with limited services, by creating inexpensive and simple POC diagnostic tools.

Based on the growing number of government-led awareness programs, the Tuberculosis Diagnostics Market presents opportunities. These programs are intended to educate the public about tuberculosis, its symptoms, and the need for early detection. As people become more conscious, a greater demand for diagnostic tests opens up new market potential.

With ongoing developments in diagnostic processes, the tuberculosis diagnostics market has potential opportunities. Innovative technologies and techniques, such as molecular diagnostics and point-of-care testing, are being developed to provide faster, more accurate, and convenient tuberculosis detection. These breakthroughs create new opportunities for improved diagnostics and fuel market growth.

Several tests, including radiological imaging, microbiological cultures, and molecular tests, are frequently needed to diagnose tuberculosis. These tests might be difficult, time-consuming, and technical to conduct and interpret. Access to diagnostic infrastructure and facilities is constrained in many settings with limited resources, especially in low-income countries. They are implemented precisely and timely. TB diagnostics can be hampered by a lack of adequately equipped laboratories, trained personnel, and a steady electricity supply.

The high costs of diagnostic testing constrain the Tuberculosis Diagnostics Market. These expenses include purchasing advanced equipment, consumables, and laboratory infrastructure. The cost of these tests constitutes a barrier, particularly in resource-constrained areas, impeding widespread adoption of tuberculosis diagnostics.

Limited reimbursement alternatives limit the market for tuberculosis diagnostics. Diagnostic test coverage and reimbursement may be inadequate in many healthcare systems, resulting in cost constraints on patients and healthcare providers. This restriction limits access to tuberculosis tests, particularly for those who cannot afford the out-of-pocket costs.

Diagnosing and treating tuberculosis can be challenging because it frequently co-occurs with infections like HIV/AIDS. Co-infections can cause overlapping symptoms, delayed diagnosis, and difficulties separating TB from other diseases. Effective solutions to this problem require integrated diagnostic strategies and interaction between TB and HIV/AIDS programs.

Many developing nations have either limited or no coverage for tuberculosis diagnostics in insurance coverage. Patients must pay for tests out of pocket, which can be a considerable financial strain. This can result in delayed diagnosis and treatment, increasing the risk of transmission and fatality.

Market Segmentations

The Global Tuberculosis Diagnostics Market is segmented based on Disease Type, Test Type, End Users, and Geography.

By Disease Type, the market is classified into Active Tuberculosis, Latent Tuberculosis Infection (LTBI), and Drug-Resistant Tuberculosis.

Active tuberculosis (TB) holds a larger share of the market for tuberculosis diagnostics. When a person has active TB, they exhibit the symptoms and warning signs of the disease and can potentially infect others. It is the type of TB that needs to be diagnosed and treated right away to stop further spread and complications.

By Test Type, the market is classified into Microbial Tests, Imaging Tests, Serological Tests, and Interferon-Gamma Release Assays (IGRAs).

Microbiological tests have a significant market share, particularly acid-fast bacilli (AFB) smear microscopy and culture-based approaches. Due to their affordability and simplicity, these tests are frequently used in settings with limited resources.

By End User, the market is classified into Hospitals and Clinics, Diagnostic Laboratories, and Research Institutes.

Diagnostics Laboratories hold a larger market share as final users. These healthcare facilities act as hubs for patient care and frequently have the equipment and trained staff to conduct TB diagnostics.

By Geography, the market is classified into the Americas, Europe, Middle-East & Africa, and Asia-Pacific.

The Americas region holds a significant market share. This is primarily because of the high rate of tuberculosis in countries with many cases of this disease.

Recent Development

The Drug Controller General of India (DCGI) granted market authorization to the Serum Institute, India, Cy-Tb kit for 18 years and above that can be used for a skin test to diagnose latent tuberculosis. – May 2022

SRL Diagnostics launched a whole genome sequencing test for tuberculosis. The test reduces the time to diagnose multi-drug resistant tuberculosis and offers a complete resistance profiling to 18 TB drugs. – March 2022

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Becton Dickinson and Co., Brucker Corp., Danaher Corp., Insilixa Inc., etc.

Countries Studied

America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)

Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxemburg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

Middle-East and Africa (Egypt, Israel, Qatar, Nigeria, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)

Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

IGR Competitive Quadrant

The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Tuberculosis Diagnostics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

Infogence Global Research analyses the Global Tuberculosis Diagnostics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, Infogence Global Research has devised suitable strategies for market growth.

Why buy this report? The report offers a comprehensive evaluation of the Global Big Data in the Fleet Management Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies. The research report also provides a detailed Market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies. Excel data sheet for the market size will also be provided with the report.The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies. The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitorsThe report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.Report Highlights: A complete analysis of the market, including the parent industryImportant market dynamics and trendsImpact Analysis – a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.Market segmentationCompetitive Analysis: Comparative analysis of competitorHistorical, current, and projected size of the market based on value and volumeMarket size of the US states Market shares and strategies of key playersRecommendations to companies for strengthening their foothold in the market